The FDA granted the Xalkori expanded use applicati
Post# of 30027
Posted On: 03/11/2016 2:22:06 PM
Quote:
The FDA granted the Xalkori expanded use application breakthrough therapy designation and priority review status.
Thats not the same as a PRV voucher is it?
And even if it is, why can't AMBS still get one?
Maybe i'm missing something?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼